You searched for side effects - Page 15 of 311 - Medivizor
Navigation Menu

A look at high intensity focused ultrasound removal of prostate gland: effects and complications

A look at high intensity focused ultrasound removal of prostate gland: effects and complications

Posted by on Oct 4, 2020 in Prostate cancer | 0 comments

In a nutshell This study investigated the short-term functional measures and complications for high-intensity focused ultrasound (HIFU) treatment in half of the prostate gland (hemi-gland) for patients with prostate cancer (PCa). The study showed that hemi-gland HIFU is a low-risk surgery and provides maintenance of sexual and urinary...

Read More

The effects of ofatumumab in combination with chemotherapy in patients with (Ph)-negative B-cell acute lymphoblastic leukemia

The effects of ofatumumab in combination with chemotherapy in patients with (Ph)-negative B-cell acute lymphoblastic leukemia

Posted by on Sep 11, 2020 in Leukemia | 0 comments

In a nutshell The study evaluated outcomes of combining ofatumumab (Arzerra) with hyper-CVAD chemotherapy in patients with Philadelphia chromosome (Ph)-negative CD20-positive B-cell acute lymphoblastic leukemia (B-ALL). The authors found that the combination was safe and effective in such patients. Some background Philadelphia chromosome (Ph) is a...

Read More

Comparing the effects of brigatinib versus crizotinib in patients with non-small cell lung carcinoma

Comparing the effects of brigatinib versus crizotinib in patients with non-small cell lung carcinoma

Posted by on Aug 30, 2020 in Lung cancer | 0 comments

In a nutshell The study evaluated outcomes of brigatinib (Alunbrig) versus crizotinib (Xalkori) in patients with non-small cell lung carcinoma (NSCLC) and anaplastic lymphoma kinase (ALK) mutations, who were previously not treated with ALK inhibitors (ALKI). The main finding was that brigatinib had better long-term outcomes compared to crizotinib in such...

Read More

What are the effects of a single injection of collagenase Clostridium histolyticum in acute phase Peyronie’s disease?

What are the effects of a single injection of collagenase Clostridium histolyticum in acute phase Peyronie’s disease?

Posted by on Aug 9, 2020 in Erectile dysfunction | 0 comments

In a nutshell This study aimed to investigate the effects of a single injection of collagenase Clostridium histolyticum (CCH; Xiapex) in early-stage Peyronie's disease (PD). The results suggested that this treatment may improve the symptoms associated with the disease. Some background Peyronie's disease (PD) is a noncancerous condition...

Read More

Differential effects of docetaxel-based chemotherapy according to body mass in patients with early breast cancer

Differential effects of docetaxel-based chemotherapy according to body mass in patients with early breast cancer

Posted by on Aug 9, 2020 in Breast cancer | 0 comments

In a nutshell The study investigated whether chemotherapy after surgery with or without docetaxel (Taxotere) has different outcomes in patients with different body mass indexes (BMI; a measurement of body weight in relation to height) and early breast cancer (BC). The main finding was that patients responded differently to docetaxel based on...

Read More

Axicabtagene ciloleucel for aggressive B-cell lymphoma outside clinical trials

Axicabtagene ciloleucel for aggressive B-cell lymphoma outside clinical trials

Posted by on Jul 28, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at axicabtagene ciloleucel (Yescarta) to treat B-cell non-Hodgkin lymphoma which has returned after previous treatment outside of clinical trials. It found that most patients responded to this immune therapy and that some patients had a complete response. Some background B-cell non-Hodgkin lymphomas (NHL) are a group of...

Read More

What are the long-term effects of prostatic artery embolization on benign prostatic hyperplasia?

What are the long-term effects of prostatic artery embolization on benign prostatic hyperplasia?

Posted by on Jul 26, 2020 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study aimed to investigate the long-term effects of prostatic artery embolization (PAE) in benign prostatic hyperplasia. The main finding was that PAE was a safe and effective long-term treatment. Some background Benign prostatic hyperplasia (BPH) is a non-cancerous condition in which the prostate gland is larger than usual....

Read More

Long term effects of hypofractionated prone intensity-modulated radiation therapy after breast conservation surgery in patients with breast cancer

Long term effects of hypofractionated prone intensity-modulated radiation therapy after breast conservation surgery in patients with breast cancer

Posted by on Jul 12, 2020 in Breast cancer | 0 comments

In a nutshell The study evaluated long-term outcomes of combining hypofractionated intensity-modulated radiation therapy (H-IMRT) with prone-positioning in patients after conservation surgery for breast cancer. The authors found that this combination safely controlled cancer locally without affecting regional lymph nodes. Some background Adjuvant...

Read More

Evaluating immune-related side effets in patients with advanced melanoma treated with immunotherapies

Evaluating immune-related side effets in patients with advanced melanoma treated with immunotherapies

Posted by on Jun 28, 2020 in Melanoma | 0 comments

In a nutshell The study monitored the occurrence of possible immune-related side effects (irSEs) in patients with advanced melanoma under single and combination therapy of ipilimumab (I; Yervoy), nivolumab (N; Opdivo), and pembrolizumab (P; Keytruda). The authors found that combination therapy increases the frequency of irSEs. Some background...

Read More

Differentiation syndrome in patients of IDH-mutated acute myeloid leukemia treated with ivosidenib and enasidenib

Differentiation syndrome in patients of IDH-mutated acute myeloid leukemia treated with ivosidenib and enasidenib

Posted by on Jun 7, 2020 in Leukemia | 0 comments

In a nutshell The study evaluated the occurrence of differentiation syndrome (DS) in patients with IDH-mutated acute myeloid leukemia (AML) under ivosidenib (Tibsovo) and enasidenib (Idhifa) therapy. The authors found that DS is a common and adverse condition in such patients. Some background Mutations or changes in the isocitrate dehydrogenase (IDH)...

Read More

What are the effects of sacral neuromodulation therapy in patients with non-responsive overactive bladder following onabotulinumtoxinA therapy?

What are the effects of sacral neuromodulation therapy in patients with non-responsive overactive bladder following onabotulinumtoxinA therapy?

Posted by on May 26, 2020 in Overactive bladder | 0 comments

In a nutshell This paper reviewed the outcomes of patients with non-responsive overactive bladder (OAB) who were treated with sacral neuromodulation (SNM) after onabotulinumtoxinA (BTX, Botox) therapy. The main finding was SNM may be successful for treating non-responsive OAB. Some background OAB is characterized by having a strong urge to...

Read More